Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking
暂无分享,去创建一个
Luigi Calzolai | Antonio Lanzavecchia | Luca Varani | Federica Sallusto | Martina Beltramello | M. Beltramello | L. Varani | F. Sallusto | A. Lanzavecchia | L. Simonelli | E. Livoti | M. Pedotti | L. Calzolai | Luca Simonelli | Mattia Pedotti | Elsa Livoti | Elsa Livoti
[1] C. Midgley,et al. Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity , 2012, The Journal of Immunology.
[2] Hugues Bedouelle,et al. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. , 2012, Structure.
[3] John McCafferty,et al. Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.
[4] Ya-jun Guo,et al. A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein , 2011, PloS one.
[5] Luca Varani,et al. Computational Docking of Antibody-Antigen Complexes, Opportunities and Pitfalls Illustrated by Influenza Hemagglutinin , 2011, International journal of molecular sciences.
[6] Jens Meiler,et al. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. , 2011, Methods in enzymology.
[7] Cameron P Simmons,et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.
[8] Luigi Calzolai,et al. Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking. , 2010, Journal of molecular biology.
[9] M. Accavitti-Loper,et al. Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. , 2009, Virology.
[10] Woonghee Lee,et al. PINE-SPARKY: graphical interface for evaluating automated probabilistic peak assignments in protein NMR spectroscopy , 2009, Bioinform..
[11] Jeffrey J. Gray,et al. RosettaAntibody: antibody variable region homology modeling server , 2009, Nucleic Acids Res..
[12] Jeffrey J. Gray,et al. Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. , 2008, Journal of molecular biology.
[13] Paolo Marcatili,et al. PIGS: automatic prediction of antibody structures , 2008, Bioinform..
[14] A. Barrett,et al. NMR assignments of the sylvatic dengue 1 virus envelope protein domain III , 2008, Biomolecular NMR assignments.
[15] Richard J Kuhn,et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins , 2008, Nature Structural &Molecular Biology.
[16] H. Lei,et al. Solution structure and neutralizing antibody binding studies of domain III of the dengue‐2 virus envelope protein , 2008, Proteins.
[17] David M. Kranz,et al. Solution mapping of T cell receptor docking footprints on peptide-MHC , 2007, Proceedings of the National Academy of Sciences.
[18] Gregory D. Gromowski,et al. Solution structure of the envelope protein domain III of dengue-4 virus. , 2007, Virology.
[19] R. Stevens,et al. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin , 2007, Nature Biotechnology.
[20] A. Barrett,et al. NMR assignment of the Dengue 4 virus envelope protein domain III , 2006, Journal of biomolecular NMR.
[21] Yi Liu,et al. RosettaDesign server for protein design , 2006, Nucleic Acids Res..
[22] Y. Modis,et al. Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein , 2005, Journal of Virology.
[23] Timothy S Baker,et al. Conformational changes of the flavivirus E glycoprotein. , 2004, Structure.
[24] K. Stiasny,et al. Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.
[25] Jeffrey J. Gray,et al. Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. , 2003, Journal of molecular biology.
[26] Y. Modis,et al. A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[28] S. Halstead,et al. Neutralization and antibody-dependent enhancement of dengue viruses. , 2003, Advances in virus research.
[29] D. Vaughn,et al. Dengue: an escalating problem , 2002, BMJ : British Medical Journal.
[30] J. Roehrig,et al. Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells , 2001, Journal of Virology.
[31] L. Kay,et al. The NMR structure of the 38 kDa U1A protein – PIE RNA complex reveals the basis of cooperativity in regulation of polyadenylation by human U1A protein , 2000, Nature Structural Biology.
[32] A Tramontano,et al. Antibody modeling: implications for engineering and design. , 2000, Methods.
[33] Duane J. Gubler,et al. Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.
[34] M. Saeed,et al. Dengue and Dengue Hemorrhagic Fever , 2015 .